Get the Stockscreener App
7.56
5.03%
-0.40
After Hours:
7.71
0.15
+1.98%
Cvrx Inc stock is traded at $7.56, with a volume of 223.73K.
It is down -5.03% in the last 24 hours and up +25.17% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$7.96
Open:
$7.75
24h Volume:
223.73K
Relative Volume:
0.69
Market Cap:
$197.11M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-2.7949
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
-9.35%
1M Performance:
+25.17%
6M Performance:
-52.69%
1Y Performance:
-8.92%
1-Day Range:
$7.50
$7.87
1-Week Range:
$7.50
$8.81
52-Week Range:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.56 | 207.54M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
127.29 | 219.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.41 | 155.22B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
377.79 | 150.09B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
89.34 | 115.62B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.33 | 46.52B | 5.69B | 4.15B | 623.10M | 6.95 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
What are the latest earnings results for CVRx Inc.Maximize your returns with portfolio optimization - jammulinksnews.com
What drives CVRX stock priceInvest confidently with data-driven strategies - jammulinksnews.com
When is CVRx Inc. stock expected to show significant growthFree Investment Community - jammulinksnews.com
What institutional investors are buying CVRx Inc. stockPowerful profit generation - jammulinksnews.com
How volatile is CVRx Inc. stock compared to the marketGet daily expert analysis for smarter investing - jammulinksnews.com
Is it the right time to buy CVRx Inc. stockBreakthrough capital growth - jammulinksnews.com
How does CVRx Inc. compare to its industry peersHigh-octane investment opportunities await - jammulinksnews.com
What catalysts could drive CVRX stock higher in 2025Unlock expert stock analysis and alerts - jammulinksnews.com
What are CVRx Inc. company’s key revenue driversBuild a winning investment strategy - jammulinksnews.com
What are CVRX company’s key revenue driversCapitalize on momentum stocks before they peak - jammulinksnews.com
Is CVRx Inc. stock overvalued or undervaluedExtraordinary market timing - jammulinksnews.com
How strong is CVRX company’s balance sheetCapitalize on market momentum for profits - jammulinksnews.com
Does CVRx Inc. stock perform well during market downturnsConsistent triple-digit returns - jammulinksnews.com
How does CVRX generate profit in a changing economyCapitalize on fast-moving stock opportunities - jammulinksnews.com
How many analysts rate CVRx Inc. as a “Buy”Free Predictions - jammulinksnews.com
Is CVRx Inc. a growth stock or a value stockExponential return rates - jammulinksnews.com
How does CVRx Inc. generate profit in a changing economyAchieve rapid capital gains with smart investing - jammulinksnews.com
What are the technical indicators suggesting about CVRXInvest confidently with advanced analysis tools - jammulinksnews.com
What analysts say about CVRX stockGet real-time alerts on high-potential stocks - jammulinksnews.com
CVRx to Report Q2 2025 Earnings on August 4, 2025, Host Conference Call - AInvest
CVRx CVRX Q2 2025 Earnings Preview Upside Potential on Analyst Optimism - AInvest
Does CVRX stock perform well during market downturnsMarket Forecast Opportunities For Every Investor - jammulinksnews.com
Real time social sentiment graph for CVRXReal-Time Trade Insights Spark Market Reactions - metal.it
Can CVRX Rally Enough to Break EvenCapital Protection Trading Strategies Gain Interest - metal.it
When TFINP stock expected to show significant growthIs CVRX stock a good long term investment optionLow Risk Trade Strategy Prediction - beatles.ru
Why CVRX stock attracts strong analyst attentionRisk Adjusted Technical Entry Plan Gains Followers - metal.it
CVRx to Present at the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Cardiovascular Tech Leader CVRx Showcases Innovation at Major Growth Conference - Stock Titan
RSI and MACD Indicate Shift in CVRx Inc. SentimentMarket Surge Signal for Swing Traders Triggered - metal.it
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
CVRx Inc. Hits Price Floor — Bounce IncomingStock Portfolio Allocation Guidance for Volatile Markets - metal.it
CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
What is CVRx Inc. company’s growth strategyMaximize gains with data-driven stock picks - jammulinksnews.com
How does CVRX compare to its industry peersSuperior investment outcomes - jammulinksnews.com
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.21%
0.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):